AIMS / HYPOTHESIS
inflammatory signals and increase the synthesis of prostaglandins play a role during the development of diabetes. The prostaglandin D2 (PGD2) receptor, GPR44 / DP2, is highly expressed in human islets and insulin secretion pathway activation results impaired. GPR44 activation role in the function of small islands and the survival rate for chronic hyperglycaemic conditions are unknown. In this study, we investigated GPR44 GPR44 inhibition by using a selective antagonist (AZ8154) in humans the island both in vitro and in vivo in diabetic mice transplanted with human islets.
METHOD
human islets exposed to PGD2 or proinflammatory cytokines in vitro to determine the effect of GPR44 inhibition on the survival rate of the island. In addition, the molecular mechanism of inhibition of GPR44 investigated in human islets exposed to high concentrations of glucose (HG) and IL-1β.
To the in vivo from this study, human islets are transplanted under the kidney capsule of diabetic rats immunodeficiencies and treated with 6, 60 or 100 mg / kg per day antagonist of GPR44 from the day of transplantation until day 4 short-term (studies) or study days (term long-17) post transplant. IVGTT conducted in rats at 10 days 15 days post transplant. After the termination of the study, metabolic variables, human circulating proinflammatory cytokines, and hepatocyte growth factor (HGF) were analyzed in human islets transplanted.
RESULTS
PGD2 or proinflammatory cytokine-induced apoptosis in human islets, while GPR44 inhibition of reverse these effects. GPR44 inhibition of hate decreased insulin secretion induced by glucose-stimulated HG and IL-1β in human islets. It is accompanied by activation of glycogen synthase kinase-Akt signaling 3β together with the phosphorylation and inactivation of the forkhead box O-1 and upregulation of pancreatic and duodenal homeobox-1 and HGF.
GPR44 antagonist administration up to 17 days for the diabetic mice transplanted with human islets resulted in a marginal reduction in fasting blood glucose and lower glucose fluctuations during IVGTT. improved glucose regulation is supported by an increased level of human C-peptide compared to the vehicle group on day 4 and throughout the treatment period. GPR44 inhibition reduces plasma levels of TNF-α and growth-regulated oncogene-α / chemokine (C-X-C motif) ligand 1 and raise the level of HGF in human islets.
Inhibition of GPR44 in human islets have the potential to improve the functioning of small islands and the survival rate under pressure inflammation and hyperglycaemic. This may have implications for the survival rates were better than the island after transplantation.
1 Channel Control Pannexin endothelial inflammation by regulating intracellular calcium.
The proinflammatory cytokine IL-1β is a significant risk factor in cardiovascular disease that can be targeted to reduce major cardiovascular events. expression and release of IL-1β is tightly controlled by changes in intracellular Ca2 + ([Ca2 +] i), which has been associated with the release of ATP and purinergic signaling. However, the mechanisms that regulate these changes have not been identified.
Interleukin 8 (IL8) Antibody |
|||
20-abx100964 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx100965 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx100966 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx100967 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx100969 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx100970 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx100971 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx100972 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx131832 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx131833 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx131834 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx131835 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx131836 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx131837 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx131838 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx131839 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx131840 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx137023 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
abx036426-100ug | Abbexa | 100 ug | EUR 469.2 |
Interleukin 8 (IL8) Antibody |
|||
abx018002-100ug | Abbexa | 100 ug | EUR 410.4 |
Interleukin 8 (IL8) Antibody |
|||
abx020956-05mg | Abbexa | 0.5 mg | EUR 1296 |
Interleukin 8 (IL8) Antibody |
|||
20-abx009111 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx270103 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx270152 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx270200 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx270201 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx173191 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
abx216289-100ug | Abbexa | 100 ug | EUR 526.8 |
Interleukin 8 (IL8) Antibody |
|||
20-abx177199 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
20-abx177201 | Abbexa |
|
|
Interleukin 8 (IL8) Antibody |
|||
abx173191-100l | Abbexa | 100 µl | EUR 287.5 |
Interleukin 8 (IL8) Antibody |
|||
abx173191-1ml | Abbexa | 1 ml | EUR 850 |
Interleukin 8 (IL8) Antibody |
|||
abx173191-200l | Abbexa | 200 µl | EUR 375 |
Interleukin 8 (IL8) Antibody |
|||
abx177199-1096tests | Abbexa | 10 × 96 tests | EUR 625 |
Interleukin 8 (IL8) Antibody |
|||
abx177199-596tests | Abbexa | 5 × 96 tests | EUR 300 |
Interleukin 8 (IL8) Antibody |
|||
abx036426-100g | Abbexa | 100 µg | EUR 337.5 |
Interleukin 8 (IL8) Antibody |
|||
abx018002-1mg | Abbexa | 1 mg | EUR 262.5 |
Interleukin 8 (IL8) Antibody |
|||
abx270152-1ml | Abbexa | 1 ml | EUR 425 |
Interleukin 8 (IL8) Antibody |
|||
abx270152-200l | Abbexa | 200 µl | EUR 300 |
Interleukin 8 (IL8) Antibody |
|||
abx131832-100g | Abbexa | 100 µg | EUR 875 |
Interleukin 8 (IL8) Antibody |
|||
abx131832-20g | Abbexa | 20 µg | EUR 375 |
Interleukin 8 (IL8) Antibody |
|||
abx131832-5g | Abbexa | 5 µg | EUR 300 |
Interleukin 8 (IL8) Antibody |
|||
abx131833-100g | Abbexa | 100 µg | EUR 812.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131833-20g | Abbexa | 20 µg | EUR 362.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131833-5g | Abbexa | 5 µg | EUR 287.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131834-100g | Abbexa | 100 µg | EUR 762.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131834-20g | Abbexa | 20 µg | EUR 337.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131834-5g | Abbexa | 5 µg | EUR 275 |
Interleukin 8 (IL8) Antibody |
|||
abx131835-100g | Abbexa | 100 µg | EUR 775 |
Interleukin 8 (IL8) Antibody |
|||
abx131835-20g | Abbexa | 20 µg | EUR 350 |
Interleukin 8 (IL8) Antibody |
|||
abx131835-5g | Abbexa | 5 µg | EUR 275 |
Interleukin 8 (IL8) Antibody |
|||
abx131836-100g | Abbexa | 100 µg | EUR 812.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131836-20g | Abbexa | 20 µg | EUR 362.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131836-5g | Abbexa | 5 µg | EUR 287.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131837-100g | Abbexa | 100 µg | EUR 812.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131837-20g | Abbexa | 20 µg | EUR 362.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131837-5g | Abbexa | 5 µg | EUR 287.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131838-100g | Abbexa | 100 µg | EUR 625 |
Interleukin 8 (IL8) Antibody |
|||
abx131838-20g | Abbexa | 20 µg | EUR 300 |
Interleukin 8 (IL8) Antibody |
|||
abx131838-5g | Abbexa | 5 µg | EUR 237.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131839-100g | Abbexa | 100 µg | EUR 762.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131839-20g | Abbexa | 20 µg | EUR 337.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131839-5g | Abbexa | 5 µg | EUR 275 |
Interleukin 8 (IL8) Antibody |
|||
abx131840-100g | Abbexa | 100 µg | EUR 762.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131840-20g | Abbexa | 20 µg | EUR 337.5 |
Interleukin 8 (IL8) Antibody |
|||
abx131840-5g | Abbexa | 5 µg | EUR 275 |
Interleukin 8 (IL8) Antibody |
|||
abx137023-01mg | Abbexa | 0.1 mg | EUR 487.5 |
Interleukin 8 (IL8) Antibody |
|||
abx177199-96tests | Abbexa | 96 tests | EUR 237.5 |
Interleukin 8 (IL8) Antibody |
|||
abx100960-100l | Abbexa | 100 µl | EUR 212.5 |
Interleukin 8 (IL8) Antibody |
|||
abx100960-1ml | Abbexa | 1 ml | EUR 475 |
Interleukin 8 (IL8) Antibody |
|||
abx100960-200l | Abbexa | 200 µl | EUR 250 |
Interleukin 8 (IL8) Antibody |
|||
abx100961-100l | Abbexa | 100 µl | EUR 250 |
Interleukin 8 (IL8) Antibody |
|||
abx100961-1ml | Abbexa | 1 ml | EUR 687.5 |
Interleukin 8 (IL8) Antibody |
|||
abx100961-200l | Abbexa | 200 µl | EUR 325 |
Interleukin 8 (IL8) Antibody |
|||
abx100962-100l | Abbexa | 100 µl | EUR 250 |
Interleukin 8 (IL8) Antibody |
|||
abx100962-1ml | Abbexa | 1 ml | EUR 687.5 |
Interleukin 8 (IL8) Antibody |
|||
abx100962-200l | Abbexa | 200 µl | EUR 325 |
Interleukin 8 (IL8) Antibody |
|||
abx100963-100l | Abbexa | 100 µl | EUR 237.5 |
Interleukin 8 (IL8) Antibody |
|||
abx100963-1ml | Abbexa | 1 ml | EUR 625 |
Interleukin 8 (IL8) Antibody |
|||
abx100963-200l | Abbexa | 200 µl | EUR 300 |
Interleukin 8 (IL8) Antibody |
|||
abx100964-100l | Abbexa | 100 µl | EUR 237.5 |
Interleukin 8 (IL8) Antibody |
|||
abx100964-1ml | Abbexa | 1 ml | EUR 625 |
Interleukin 8 (IL8) Antibody |
|||
abx100964-200l | Abbexa | 200 µl | EUR 300 |
Interleukin 8 (IL8) Antibody |
|||
abx100965-100l | Abbexa | 100 µl | EUR 250 |
Interleukin 8 (IL8) Antibody |
|||
abx100965-1ml | Abbexa | 1 ml | EUR 650 |
Interleukin 8 (IL8) Antibody |
|||
abx100965-200l | Abbexa | 200 µl | EUR 312.5 |
Interleukin 8 (IL8) Antibody |
|||
abx100966-100l | Abbexa | 100 µl | EUR 262.5 |
Interleukin 8 (IL8) Antibody |
|||
abx100966-1ml | Abbexa | 1 ml | EUR 687.5 |
Interleukin 8 (IL8) Antibody |
|||
abx100966-200l | Abbexa | 200 µl | EUR 325 |
Interleukin 8 (IL8) Antibody |
|||
abx100967-100l | Abbexa | 100 µl | EUR 262.5 |
Interleukin 8 (IL8) Antibody |
|||
abx100967-1ml | Abbexa | 1 ml | EUR 712.5 |
Interleukin 8 (IL8) Antibody |
|||
abx100967-200l | Abbexa | 200 µl | EUR 325 |
Interleukin 8 (IL8) Antibody |
|||
abx100969-100l | Abbexa | 100 µl | EUR 275 |
Interleukin 8 (IL8) Antibody |
|||
abx100969-1ml | Abbexa | 1 ml | EUR 775 |
Interleukin 8 (IL8) Antibody |
|||
abx100969-200l | Abbexa | 200 µl | EUR 350 |
Interleukin 8 (IL8) Antibody |
|||
abx100971-100l | Abbexa | 100 µl | EUR 287.5 |
Interleukin 8 (IL8) Antibody |
|||
abx100971-1ml | Abbexa | 1 ml | EUR 825 |
Interleukin 8 (IL8) Antibody |
|||
abx100971-200l | Abbexa | 200 µl | EUR 362.5 |
Interleukin 8 (IL8) Antibody |
|||
abx100972-100l | Abbexa | 100 µl | EUR 300 |
Interleukin 8 (IL8) Antibody |
|||
abx100972-1ml | Abbexa | 1 ml | EUR 875 |
Interleukin 8 (IL8) Antibody |
|||
abx100972-200l | Abbexa | 200 µl | EUR 375 |
IL8 (untagged)-Human interleukin 8 (IL8) |
|||
SC119807 | Origene Technologies GmbH | 10 µg | Ask for price |
Dog Interleukin-8 (IL8) |
|||
1-CSB-YP011671DO | Cusabio |
|
|
Description: Recombinant Dog Interleukin-8(IL8) expressed in Yeast |
Dog Interleukin-8 (IL8) |
|||
1-CSB-EP011671DO | Cusabio |
|
|
Description: Recombinant Dog Interleukin-8(IL8) expressed in E.coli |
Dog Interleukin-8 (IL8) |
|||
1-CSB-MP011671DO | Cusabio |
|
|
Description: Recombinant Dog Interleukin-8(IL8) expressed in Mammalian cell |
Active Interleukin 8 (IL8) |
|||
APA080Bo61 | Cloud-Clone | 10ug | EUR 302 |
Active Interleukin 8 (IL8) |
|||
APA080Ga01 | Cloud-Clone | 10ug | EUR 346 |
Active Interleukin 8 (IL8) |
|||
APA080Hu01 | Cloud-Clone | 10ug | EUR 147 |
Active Interleukin 8 (IL8) |
|||
4-APA080Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Interleukin 8 expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells |
Active Interleukin 8 (IL8) |
|||
APA080Po01 | Cloud-Clone | 10ug | EUR 346 |
Active Interleukin 8 (IL8) |
|||
APA080Rb01 | Cloud-Clone | 10ug | EUR 346 |
Active Interleukin 8 (IL8) |
|||
APA080Si01 | Cloud-Clone | 10ug | EUR 346 |
Sheep Interleukin-8 (IL8) |
|||
1-CSB-EP011671SH | Cusabio |
|
|
Description: Recombinant Sheep Interleukin-8(IL8) expressed in E.coli |
Active Interleukin 8 (IL8) |
|||
RPU55475-100ug | Biomatik Corporation | 100ug | EUR 453.2 |
Active Interleukin 8 (IL8) |
|||
RPU55475-1mg | Biomatik Corporation | 1mg | EUR 2009.8 |
Active Interleukin 8 (IL8) |
|||
RPU55475-50ug | Biomatik Corporation | 50ug | EUR 364.1 |
Active Interleukin 8 (IL8) |
|||
RPU59242-100ug | Biomatik Corporation | 100ug | EUR 1140.2 |
Active Interleukin 8 (IL8) |
|||
RPU59242-1mg | Biomatik Corporation | 1mg | EUR 5054.4 |
Active Interleukin 8 (IL8) |
|||
RPU59242-50ug | Biomatik Corporation | 50ug | EUR 760.3 |
Active Interleukin 8 (IL8) |
|||
MBS2122275-001mg | MyBiosource | 0.01mg | EUR 260 |
Active Interleukin 8 (IL8) |
|||
MBS2122275-005mg | MyBiosource | 0.05mg | EUR 555 |
Active Interleukin 8 (IL8) |
|||
MBS2122275-01mg | MyBiosource | 0.1mg | EUR 850 |
Active Interleukin 8 (IL8) |
|||
MBS2122275-02mg | MyBiosource | 0.2mg | EUR 1055 |
Active Interleukin 8 (IL8) |
|||
MBS2122275-05mg | MyBiosource | 0.5mg | EUR 2050 |
Active Interleukin 8 (IL8) |
|||
MBS2105072-001mg | MyBiosource | 0.01mg | EUR 160 |
Active Interleukin 8 (IL8) |
|||
MBS2105072-005mg | MyBiosource | 0.05mg | EUR 265 |
Active Interleukin 8 (IL8) |
|||
MBS2105072-01mg | MyBiosource | 0.1mg | EUR 395 |
Active Interleukin 8 (IL8) |
|||
MBS2105072-02mg | MyBiosource | 0.2mg | EUR 480 |
The pannexin 1 (Panx1) channel has been canonically been involved in the ATP release, particularly during inflammation. We checked Panx1 in human umbilical vein endothelial cells after treatment with proinflammatory cytokines TNF-α. Analysis by the whole transcriptome sequencing and immunoblot Panx1 identified a dramatic increase in mRNA and protein expression were regulated by NF-kB-dependent.